A polymorphism in the gene encoding the Fcgamma IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis.
作者信息
Tsukahara S, Ikari K, Sato E, Yamanaka H, Hara M, Tomatsu T, Momohara S, Kamatani N
出版信息
Ann Rheum Dis. 2008 Dec;67(12):1791-2. doi: 10.1136/ard.2007.086892.
PMID:19005160
Abstract
摘要
Zotero 插件